Status:
COMPLETED
Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18-80 years
Brief Summary
Approximately, post-traumatic stress disorder (PTSD) occurs in 8% of the adult population over time. Exposure to traumatic events increases the risk of poor physical health and often leads to disabili...
Detailed Description
Lifetime prevalence of post-traumatic stress disorder (PTSD) is estimated at 8%. Exposure to traumatic events increases the risk of poor physical health, and chronic PTSD often leads to disability. Th...
Eligibility Criteria
Inclusion
- Age 18-80
- history of PTSD
Exclusion
- Uncontrolled medical or psychiatric conditions Liver or kidney disease Use of anti-depressants or ketoconazole Use of steroids within a year of the study Use of drugs of abuse Pregnancy or nursing Metal implants Low testosterone states A history of head bleeds or pituitary tumors
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00815204
Start Date
May 1 2008
End Date
July 1 2014
Last Update
February 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048